Skip to main content

Published locations for Canagliflozin falls short for primary CV prevention in T2DM

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Canagliflozin falls short for primary CV prevention in T2DM

User login

  • Reset your password
  • /content/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /familypracticenews/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /internalmedicinenews/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /vascularspecialistonline/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention
  • /clinicalendocrinologynews/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention
  • /diabeteshub/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /ecardiologynews/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /cardiology/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /endocrinology/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /internalmedicine/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /familymedicine/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm
  • /type-2-diabetes-icymi/article/157717/diabetes/canagliflozin-falls-short-primary-cv-prevention-t2dm